Skip to main content

Colon Conduit Urinary Diversion

Colon conduit urinary diversion (CCUD) is an incontinent supravesical diversion that uses an isolated segment of colon — most commonly the transverse colon, but also the sigmoid or descending colon — as a conduit to drain urine from the ureters to an abdominal stoma. It is the principal alternative to the ileal conduit when small bowel is unsuitable, particularly after pelvic radiation, in short bowel, or when a colostomy is already planned.

Indications​

The colon conduit is not a first-line choice for most patients undergoing urinary diversion; rather, it is selected when specific clinical circumstances preclude the use of ileum.

  • Prior pelvic radiation therapy. The transverse colon, situated in the upper abdomen, is typically spared from pelvic radiation fields, making it the preferred conduit segment in previously irradiated patients. Irradiated ileum and sigmoid carry increased risks of anastomotic complications and fibrosis.[1][2]
  • Pelvic exenteration with concurrent colostomy. When a colostomy is already planned or present, the distal colon can serve as the urinary conduit, converting the existing colostomy to a urinary stoma and creating a new proximal colostomy for fecal diversion. This avoids a separate bowel anastomosis entirely.[3][4]
  • Short bowel syndrome or prior extensive small-bowel resection. Preserving ileal length is critical in these patients; a colon conduit allows the ileum to remain in continuity.[5]
  • Hostile abdomen with extensive small-bowel adhesions.[6]
  • Neurogenic bladder, bladder exstrophy, and pelvic malignancies in pediatric and adult populations.[7]
  • Inflammatory bowel disease affecting the small bowel (e.g., Crohn's disease).[8]

In the largest multi-institutional CCUD series (n = 179), prior radiation therapy (63.7%), prior abdominal surgery (72%), and prior genitourinary surgery (54%) were common among patients selected for colon conduit.[6]

Colonic Segments​

  • Transverse colon. Most commonly used, especially after pelvic radiation, because it lies above the radiation field and has a reliable blood supply from the middle colic artery. Allows high ureteral anastomosis above irradiated tissue.[2][9]
  • Sigmoid colon. Used when the distal colon is available and a concurrent colostomy is planned, avoiding the need for a separate bowel anastomosis.[3]
  • Descending colon. Similar advantages to sigmoid when used in conjunction with colostomy.[3]

Surgical Technique​

The general principles mirror those of ileal conduit construction, adapted for colonic anatomy.

  1. Segment isolation. A 15–20 cm segment of colon is isolated on its mesentery, preserving the vascular pedicle (middle colic artery for transverse colon; inferior mesenteric artery branches for sigmoid / descending).[9][10]
  2. Bowel continuity. A colocolonic anastomosis restores bowel continuity. Alternatively, in patients undergoing concurrent colostomy, the conduit can be fashioned from the distal limb, avoiding any bowel anastomosis.[3][4]
  3. Ureteral implantation. Ureters are anastomosed to the proximal end of the conduit by one of two approaches:
    • Refluxing (Wallace-type). End-to-end or end-to-side ureterocolic anastomosis with free reflux. Technically simpler and allows retrograde conduitography for surveillance.[9][11]
    • Non-refluxing (submucosal tunnel). The thicker colonic wall facilitates a submucosal tunnel for anti-reflux ureteral implantation, a theoretical advantage over ileal conduit. However, this technique carries an 8–10% risk of ureterocolonic stricture.[9][12]
  4. Stoma creation. The distal end of the conduit is brought through the abdominal wall as a stoma, typically in the right or left lower quadrant depending on the segment used.

A unique configuration is the "colostomy switch" — in patients with a pre-existing colostomy, the colostomy site is converted to the urinary stoma and a new proximal colostomy is created for fecal diversion.[4][6] This is conceptually adjacent to the colon shuffle maneuver in complex pelvic exenteration.

Outcomes​

Perioperative outcomes from the largest multi-institutional study (n = 179):[6]

OutcomeRate
30-day high-grade complications (Clavien ≥ III)28.5%
30–90 day high-grade complications14.5%
90-day mortality4.5%
90-day reintervention (surgical / procedural)30.2%
Most common late complication (ureteral stent / nephrostomy)16.8%

Key prognostic factors:[6]

  • Preoperative albumin ≥ 3.2 g/dL was strongly protective against 30–90 day high-grade complications (HR 0.18).
  • A high-grade complication in the first 30 days was associated with a 2.85-fold increased risk of a secondary high-grade complication between days 30–90.
  • Concurrent colonic anastomosis at the time of CCUD was not associated with worse 30-day outcomes.

Colon Conduit vs. Ileal Conduit​

In a comparative study of 259 patients undergoing pelvic exenteration for rectal cancer (214 ileal conduit, 45 colon conduit):[13]

  • Colon conduit was associated with lower postoperative ileus (7% vs. 21%, p = 0.024).
  • Colon conduit eliminated the risk of ileo-ileal anastomotic leakage (which occurred in 4% of ileal conduit patients).
  • No significant differences in uretero-enteric anastomotic leakage, major complications (Clavien-Dindo ≥ 3), mortality, or hospital stay.

A prospective comparison of 130 high-risk patients found that ileal conduit had a higher rate of major diversion-related complications (18.1%) and late surgical reintervention (20%) compared with colon conduit (5.8% for both).[14] The colon conduit group, however, had higher baseline comorbidity, complicating direct comparison.

Metabolic Complications​

Like ileal conduits, colon conduits expose urine to intestinal mucosa, leading to predictable metabolic derangements through reabsorption of urinary solutes.[15]

  • Hyperchloremic metabolic acidosis — the most clinically significant metabolic complication, caused by chloride–bicarbonate exchange across the colonic mucosa. Reported in 34.1% of patients at ≥ 90 days. Managed with oral sodium bicarbonate or sodium citrate supplementation.[3][15][16]
  • Hypokalemia — reported in 39% at ≥ 90 days, likely related to colonic potassium secretion.[3]
  • Hyperchloremia — reported in 24.4%.[3]
  • Calcium and magnesium wasting — chronic acidosis and sulfate reabsorption inhibit renal tubular calcium and magnesium reabsorption, contributing to osteoporosis risk.[17]
  • Vitamin B12 deficiency — less of a concern with colon conduit than with ileal conduit, since B12 is absorbed in the terminal ileum.[15]
  • Urolithiasis — long-term risk from chronic metabolic acidosis and altered urinary composition.[18]

Early literature suggested that colon conduits may produce less electrolyte disturbance than ileal conduits because of shorter contact time and different absorptive properties of colonic mucosa.[9]

Long-Term Complications​

In a Mayo Clinic series of 1,057 conduit diversions (ileum or colon) with median follow-up of 15.5 years among survivors, 60.8% of patients developed at least one diversion-related complication, with a mean of 2.3 complications per patient:[18]

DomainRate
Bowel complications20.3%
Renal complications20.2%
Infectious complications16.5%
Stomal complications15.4%
Urolithiasis15.3%
Metabolic abnormalities12.8%
Structural complications11.5%

Specific to colon conduit, ureterocolonic stricture remains a notable concern, particularly with non-refluxing anastomoses, occurring in 8–10% of patients.[12] Strategies to minimize stricture include preservation of periureteral adventitia, tension-free anastomosis, and careful submucosal tunnel construction.[12]

Contraindications​

  • Inflammatory bowel disease affecting the colon (e.g., ulcerative colitis).
  • Previously irradiated colon segment (for that specific segment).
  • Fecal incontinence or poor anal sphincter tone (if staged ureterosigmoidostomy is planned).[19]
  • Strong family history of colon cancer (relative contraindication for long-term diversion).[19]
  • Inadequate ureteral length for colonic anastomosis.[19]

Advantages​

  • Avoids use of irradiated bowel when transverse colon is selected.[2]
  • Thicker colonic wall facilitates non-refluxing ureteral implantation.[9][12]
  • Minimal stomal stenosis compared with ileal conduit.[9]
  • Less residual urine in the conduit.[9]
  • Can eliminate the need for any bowel anastomosis when combined with colostomy.[3][4]
  • Lower rate of postoperative ileus than ileal conduit.[13]
  • Potentially lower rate of vitamin B12 deficiency.[15]

Summary​

Colon conduit urinary diversion remains an important alternative to ileal conduit, particularly in patients with prior pelvic radiation, short bowel, concurrent need for colostomy, or hostile abdominal anatomy. Outcomes are comparable to ileal conduit with respect to major complications and mortality, and the colon conduit may offer advantages in specific clinical scenarios. Long-term surveillance for metabolic derangements, ureterocolonic stricture, and renal function is essential.[6][8][18]

References​

1. Höckel M, Dornhöfer N. "Pelvic Exenteration for Gynaecological Tumours: Achievements and Unanswered Questions." Lancet Oncol. 2006;7(10):837–47. doi:10.1016/S1470-2045(06)70903-2

2. Schmidt JD, Hawtrey CE, Buchsbaum HJ. "Transverse Colon Conduit: A Preferred Method of Urinary Diversion for Radiation-Treated Pelvic Malignancies." J Urol. 1975;113(3):308–13. doi:10.1016/s0022-5347(17)59469-0

3. Alemozaffar M, Nam CS, Said MA, et al. "Avoiding the Need for Bowel Anastomosis During Pelvic Exenteration — Urinary Sigmoid or Descending Colon Conduit — Short and Long-Term Complications." Urology. 2019;129:228–33. doi:10.1016/j.urology.2019.03.015

4. Davis BE, Noble MJ. "Simplified Urinary Diversion in Patients with Preexisting or Imminent Colostomy." J Urol. 1992;147(5):1245–7. doi:10.1016/s0022-5347(17)37529-8

5. Kaveggia FF, Thompson JS, Taylor RJ. "Placement of an Ileal Loop Urinary Diversion Back in Continuity with the Intestinal Tract." Surgery. 1991;110(3):557–60.

6. Hebert KJ, Swinney S, Johnson R, et al. "Outcomes After Colon Conduit Urinary Diversion: A Multi-Institutional Retrospective Study from the Reconstruction and Diversion: Improving Outcomes Group." J Urol. 2026;215(5):621–32. doi:10.1097/JU.0000000000004935

7. Hendren WH. "Nonrefluxing Colon Conduit for Temporary or Permanent Urinary Diversion in Children." J Pediatr Surg. 1975;10(3):381–98. doi:10.1016/0022-3468(75)90105-2

8. Sperling CD, Lee DJ, Aggarwal S. "Urinary Diversion: Core Curriculum 2021." Am J Kidney Dis. 2021;78(2):293–304. doi:10.1053/j.ajkd.2020.12.023

9. Morales P, Golimbu M. "Colonic Urinary Diversion: 10 Years of Experience." J Urol. 1975;113(3):302–7. doi:10.1016/s0022-5347(17)59468-9

10. Cody JD, Nabi G, Dublin N, et al. "Urinary Diversion and Bladder Reconstruction / Replacement Using Intestinal Segments for Intractable Incontinence or Following Cystectomy." Cochrane Database Syst Rev. 2012;(2):CD003306. doi:10.1002/14651858.CD003306.pub2

11. Beckley S, Wajsman Z, Pontes JE, Murphy G. "Transverse Colon Conduit: A Method of Urinary Diversion After Pelvic Irradiation." J Urol. 1982;128(3):464–8. doi:10.1016/s0022-5347(17)52999-7

12. Dagen JE, Sanford EJ, Rohner TJ. "Complications of the Non-Refluxing Colon Conduit." J Urol. 1980;123(4):585–7. doi:10.1016/s0022-5347(17)56031-0

13. Hagemans JAW, Voogt ELK, Rothbarth J, et al. "Outcomes of Urinary Diversion After Surgery for Locally Advanced or Locally Recurrent Rectal Cancer with Complete Cystectomy; Ileal and Colon Conduit." Eur J Surg Oncol. 2020;46(6):1160–6. doi:10.1016/j.ejso.2020.02.021

14. Pycha A, Comploj E, Martini T, et al. "Comparison of Complications in Three Incontinent Urinary Diversions." Eur Urol. 2008;54(4):825–32. doi:10.1016/j.eururo.2008.04.068

15. Roth JD, Koch MO. "Metabolic and Nutritional Consequences of Urinary Diversion Using Intestinal Segments to Reconstruct the Urinary Tract." Urol Clin North Am. 2018;45(1):19–24. doi:10.1016/j.ucl.2017.09.007

16. Koch MO, McDougal WS. "Nicotinic Acid: Treatment for the Hyperchloremic Acidosis Following Urinary Diversion Through Intestinal Segments." J Urol. 1985;134(1):162–4. doi:10.1016/s0022-5347(17)47048-0

17. McDougal WS, Koch MO. "Effect of Sulfate on Calcium and Magnesium Homeostasis Following Urinary Diversion." Kidney Int. 1989;35(1):105–15. doi:10.1038/ki.1989.15

18. Shimko MS, Tollefson MK, Umbreit EC, et al. "Long-Term Complications of Conduit Urinary Diversion." J Urol. 2011;185(2):562–7. doi:10.1016/j.juro.2010.09.096

19. Nieh PT, Althausen AF, Dretler SP. "Staged Ureterocolocolostomy Urinary Diversion." J Urol. 1978;120(4):402–6. doi:10.1016/s0022-5347(17)57199-2